Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe.
Schulz C, Martina B, Mirolo M, Müller E, Klein R, Volk H, Egberink H, Gonzalez-Hernandez M, Kaiser F, von Köckritz-Blickwede M, Osterhaus A. Schulz C, et al. Emerg Infect Dis. 2021 Dec;27(12):3115-3118. doi: 10.3201/eid2712.211252. Epub 2021 Oct 25. Emerg Infect Dis. 2021. PMID: 34695368 Free PMC article.
Combined Prospective Seroconversion and PCR Data of Selected Cohorts Indicate a High Rate of Subclinical SARS-CoV-2 Infections-an Open Observational Study in Lower Saxony, Germany.
Jonczyk R, Stanislawski N, Seiler LK, Blume H, Heiden S, Lucas H, Sarikouch S, Pott PC, Stiesch M, Hauß C, Saletti G, González-Hernández M, Kaiser FK, Rimmelzwaan G, Osterhaus A, Blume C. Jonczyk R, et al. Microbiol Spectr. 2022 Feb 23;10(1):e0151221. doi: 10.1128/spectrum.01512-21. Epub 2022 Feb 16. Microbiol Spectr. 2022. PMID: 35171028 Free PMC article.
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern.
Du W, Hurdiss DL, Drabek D, Mykytyn AZ, Kaiser FK, González-Hernández M, Muñoz-Santos D, Lamers MM, van Haperen R, Li W, Drulyte I, Wang C, Sola I, Armando F, Beythien G, Ciurkiewicz M, Baumgärtner W, Guilfoyle K, Smits T, van der Lee J, van Kuppeveld FJM, van Amerongen G, Haagmans BL, Enjuanes L, Osterhaus ADME, Grosveld F, Bosch BJ. Du W, et al. Sci Immunol. 2022 Jul 29;7(73):eabp9312. doi: 10.1126/sciimmunol.abp9312. Epub 2022 Jul 29. Sci Immunol. 2022. PMID: 35471062 Free PMC article.
Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity.
Jonczyk R, Stanislawski N, Seiler LK, Ahani S, Bueltemeier A, Stahl F, Beutel S, Blume H, Hauß C, Melk A, Paulsen M, Stiesch M, Winkel A, Pott PC, Saletti G, González-Hernández M, Kaiser FK, Rimmelzwaan GF, Osterhaus ADME, Blume C. Jonczyk R, et al. J Clin Virol. 2022 Dec;157:105322. doi: 10.1016/j.jcv.2022.105322. Epub 2022 Oct 17. J Clin Virol. 2022. PMID: 36279696 Free PMC article.
Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event.
Ten Hagen NA, Twele F, Meller S, Wijnen L, Schulz C, Schoneberg C, Kreienbrock L, von Köckritz-Blickwede M, Osterhaus A, Boeck AL, Boeck K, Bonda V, Pilchová V, Kaiser FK, Gonzalez Hernandez M, Ebbers H, Hinsenkamp J, Pink I, Drick N, Welte T, Manns MP, Illig T, Puyskens A, Nitsche A, Ernst C, Engels M, Schalke E, Volk HA. Ten Hagen NA, et al. BMJ Glob Health. 2022 Nov;7(11):e010276. doi: 10.1136/bmjgh-2022-010276. BMJ Glob Health. 2022. PMID: 36368765 Free PMC article.
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1.
Gonzalez-Hernandez M, Kaiser FK, Steffen I, Ciurkiewicz M, van Amerongen G, Tchelet R, Emalfarb M, Saloheimo M, Wiebe MG, Vitikainen M, Albulescu IC, Bosch BJ, Baumgärtner W, Haagmans BL, Osterhaus ADME. Gonzalez-Hernandez M, et al. Front Immunol. 2023 Jun 9;14:1204834. doi: 10.3389/fimmu.2023.1204834. eCollection 2023. Front Immunol. 2023. PMID: 37359531 Free PMC article.
136 results